| Similar Articles |
|---|
 |
BusinessWeek
April 18, 2005
Manjeet Kripalani |
India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India.   |
BusinessWeek
February 27, 2006
Einhorn & Kripalani |
In India, Selling Generics Used To Be So Easy Suddenly, Indian drugmakers Dr. Reddy's and Ranbaxy have a host of copycat rivals. |
BusinessWeek
October 18, 2004
Manjeet Kripalani |
The Factories Are Humming In India Indian manufacturing is surprisingly strong and fueling an export boom. |
BusinessWeek
January 12, 2004
Manjeet Kripalani |
India: Big Pharma's New Promised Land? Drugmakers are heeding the siren call of its well-trained, cheap chemists. |
BusinessWeek
June 20, 2005
Manjeet Kripalani |
Private Equity Pours Into India A lucrative Warburg Pincus deal sends a signal to other firms: There's big money to be made in India. |
BusinessWeek
July 31, 2006
Pete Engardio |
Emerging Giants Multinationals from China, India, Brazil, Russia, and even Egypt are coming on strong. They're hungry - and want your customers. They're changing the global game. |
BusinessWeek
February 2, 2004
Manjeet Kripalani |
The Rush To Cash In On India Sizzling growth and an undervalued market have buyers lining up for IPOs. |
BusinessWeek
April 26, 2004
Kripalani & Hamm |
Merger Fever Breaks Out In Bangalore IBM's $150 million purchase of Daksh eServices, the third-largest Indian call center and back-office service provider, may trigger a wave of acquisitions. |
HBS Working Knowledge
February 14, 2007
Tarun Khanna |
Tata-Corus: India's New Steel Giant Tata's acquisition of Corus is notable not only for creating a new steel giant, but also because this deal was a private sector venture far from Indian government influence. |
The Motley Fool
August 30, 2006
Brian Gorman |
Mylan's Biogeneric Play The generic drugmaker buys an Indian firm to strengthen its long-term prospects. Investors, take note. |
BusinessWeek
August 13, 2007
Pete Engardio |
The Last Rajah India's Ratan Tata aims to transform his once-stodgy conglomerate into a global powerhouse. But can it thrive after he steps down? |
IndustryWeek
July 22, 2009 |
The Promise of India Big, young, educated and ambitious. Can India become the next industrial superpower? |
Financial Advisor
July 2011
Alan Lavine |
Tiger Versus Dragon Despite huge challenges in China and India, investors expect rising wages, increased domestic demand and exports to accelerate business growth. |
BusinessWeek
July 26, 2004
Manjeet Kripalani |
Ratan Tata: No One's Doubting Now The Tata group has interests from autos and steel to software and telecom and is prospering as India's economy booms. Ratan Tata has transformed Tata group from an overgrown conglomerate into an agile global force. |
Pharmaceutical Executive
October 1, 2011
Amrita Ghaswalla |
Changing the Dialogue No industry leader is more closely associated with the goal of seeding the globe with low-cost generics than Mumbai-based Cipla Chairman Y.K. Hamied. |
BusinessWeek
August 6, 2007
Kripalani & Lakshman |
Rise Of The Rupee Tech companies and exporters are losing profits as the India's currency continues to rise. |
BusinessWeek
November 4, 2010
Einhorn & Gokhale |
India Outsourcers Feel Unloved in the U.S. Indian outsourcers fear that a U.S. backlash over job losses will endanger their biggest overseas market. |
IndustryWeek
August 1, 2006
Jonathan Katz |
Auto Parts: The New Kid In Town U.S. auto-components manufacturers take note: India wants your customers. |
CFO
February 1, 2008
Tom Leander |
View from Asia: India Starts Buying American Why Indian firms tread lightly when they acquire overseas. |
Chemistry World
July 25, 2012 |
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. |
BusinessWeek
September 3, 2007
Manjeet Kripalani |
A Red-Hot Big Blue In India From inking deals to hiring the best workers, IBM is leading its tech services rivals in India. |
InternetNews
March 26, 2004
Sean Michael Kerner |
Outsourcing Comes to India IT operations at Bharti Tele-Ventures Ltd. are being turned over to IBM India in a deal which could be worth up to $750 million dollars over 10 years. |
BusinessWeek
January 8, 2007
Nandini Lakshman |
Private Equity Invades India Strong growth and a hot market have foreign investors pouring in billions. |
BusinessWeek
October 20, 2003
Manjeet Kripalani |
India's Manufacturers In Shackles Without labor-law reform, Indian industries are likely to lose out to China. |
BusinessWeek
August 13, 2007 |
Tata Unbound A talk with India's Ratan N. Tata reveals his take on everything from Tata Group's expansion plans, to being overstretched, to choosing a successor. |
BusinessWeek
November 20, 2006
Brian Bremner |
The Dragon's Way Or The Tiger's? A spirited debate over the merits of directed vs. democratic economies |
BusinessWeek
December 8, 2003
Kripalani & Engardio |
The Rise Of India Growth is only just starting, but the country's brainpower is already reshaping Corporate America |
BusinessWeek
November 7, 2005
Manjeet Kripalani |
India: Desperately Seeking Talent As India's economy booms, companies are scrambling to find, and keep, skilled workers. |
BusinessWeek
June 21, 2004
Manjeet Kripalani |
Now It's Bombay Calling The U.S. In the past two years Indian companies have snapped up a dozen U.S. call centers and business processing outsourcers. |
Reason
June 2006
Samuel R. Staley |
The Rise and Fall of Indian Socialism Why India embraced economic reform. |
Chemistry World
March 20, 2012
Rajesh Parishwad |
India Green Lights Production of Patented Cancer Drug For the first time India has invoked a 'compulsory license' clause to cut the cost of a patented anti-cancer drug by allowing another company to manufacture the therapy. |
BusinessWeek
November 15, 2004
Manjeet Kripalani |
How a Thirst for Energy Led to a Thaw As India's economy undergoes a dramatic expansion, it finds itself desperate for new supplies of oil, gas, and electricity. And diplomacy -- even with fierce rival Pakistan -- is one way of getting them. |
The Motley Fool
April 12, 2011
Brian Orelli |
Merck Joins the Low-Margin Party The American drugmaker announces that it is partnering with Sun Pharma to establish a joint venture to sell branded generics in emerging markets. |
The Motley Fool
April 14, 2011
Suman Chatterjee |
U.S. Hotels Heading Toward Indian Shores Marriott is leading the way, and others may follow soon. |
BusinessWeek
August 4, 2003
Bruce Einhorn |
Outsourcing: Make Way for China It's fast becoming an important hub for IT services. Move over, India. |
The Motley Fool
February 18, 2009
Ivan Martchev |
3 Stock Ideas From an Emerging Powerhouse India's been hammered in the past year, but stocks are starting to look appealing again. Take a look at: Dr. Reddy's Laboratories... HDFC Bank... ICICI Bank... |
IndustryWeek
December 1, 2008
Adrienne Selko |
Consider the Total Tax Package When Looking To Locate in India India is very competitive when you factor in the many tax incentives offered to foreign companies. |
BusinessWeek
April 17, 2006
Manjeet Kripalani |
Open Season On Outsourcers More Western software and services companies are snapping up Indian companies that specialize in back-office operations. |
The Motley Fool
May 21, 2010
Brian Orelli |
Abbott Learns to Say "Low Margin" in Hindi No matter what country, overpaying isn't a good idea. |
The Motley Fool
September 9, 2010
Andrew Bond |
Invest in India for Fast Growth Consider these strong Indian companies for your portfolio. |
BusinessWeek
January 26, 2004
Kripalani & Hamm |
Scrambling To Stem India's Onslaught Now big Western service outfits have to fight back on both the high and low ends. |
The Motley Fool
May 11, 2010
Brian Orelli |
Abbott Makes a Push Into Selling Leftovers Abbott Labs has jumped on the established-product-division bandwagon. The company has licensed 24 products from Zydus Cadila of India and has the option to market another 40. |
BusinessWeek
May 6, 2010
Bruce Einhorn |
A Setback for China's Tech Ambitions in India Chinese tech companies had been counting on India for growth, but security concerns have spurred New Delhi to limit imports from China. |
BusinessWeek
December 3, 2007
Balfour & Kripalani |
The Coming Commodity Clash Voracious demand from fast-developing countries sets the stage for a face-off over industrial assets. |
The Motley Fool
March 28, 2005
Brian Gorman |
A Passage to India? Changes in India's patent law could create new dynamics for the biotech and pharmaceutical industries. Investors should be on the lookout for the firms that seek to leverage these new opportunities. |
Chemistry World
April 9, 2014
Andy Extance |
Sun set on Ranbaxy rescue India's Sun Pharma will acquire its compatriot Ranbaxy in a $3.2 billion all-share deal that will create the world's fourth largest generic drugs producer. |
The Motley Fool
November 23, 2009
Jennifer Schonberger |
Here's Where to Invest in India The portfolio manager for T. Rowe Price's New Asia Fund gives some thoughts on investing in India. |
InternetNews
August 27, 2004
Colin C. Haley |
India Worth More Than Outsourcing Telecom vendors pursue a burgeoning Indian market for products and services while mindful that some hurdles remain. |
Entrepreneur
March 2007
Laurel Delaney |
Currying Favor Here's how to win over India's consumers. |
IEEE Spectrum
June 2007
Seema Singh |
Delhi's Defense Spending Spree As India upgrades its arsenal, U.S. military contractors hope to cash in. |
